Travere Therapeutics Stock Forecast

Buy or Hold candidate since Apr 15, 2026 Gain 43.71%

The Travere Therapeutics, Inc. stock price fell by -0.305% on the last day (Friday, 26th Jun 2026) from $59.03 to $58.85. During the last trading day the stock fluctuated 3.67% from a day low at $57.69 to a day high of $59.81. The price has risen in 7 of the last 10 days and is up by 20.32% over the past 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $288.15 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $59.42 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 69.45% during the next 3 months and, with a 90% probability hold a price between $84.11 and $100.69 at the end of this 3-month period.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $56.56 and $47.98. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 25, 2026, and so far it has fallen -0.305%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $55.15 and $47.76. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Travere Therapeutics, Inc. finds support just below today's level at $55.15. If this is broken, then the next support from accumulated volume will be at $47.76 and $44.80.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.12 between high and low, or 3.67%. For the last week, the stock has had daily average volatility of 3.72%.

The Travere Therapeutics, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $57.44 (-2.40%) (This stock has high daily movements and this gives high risk. The RSI14 is 86 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Travere Therapeutics, Inc. to open at $58.78, and during the day (based on 14 day Average True Range), to move between $57.71 and $59.99, which gives a possible trading interval of +/-$2.28 (+/-3.96%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 3.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $59.03 (0.31%) than the support at $55.15 (6.29%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Travere Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.971 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $58.78 ( 0.113%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk